Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (50)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by CHRISTENSEN, H.
Right arrow Articles by BROE, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHRISTENSEN, H.
Right arrow Articles by BROE, G. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 115, No. 6, 1681-1699, 1992
© 1992 Guarantors of Brain


research-article

CHOLINERGIC ‘BLOCKADE’ AS A MODEL OF THE COGNITIVE DEFICITS IN ALZHEIMER'S DISEASE

H. CHRISTENSEN1, N. MALTBY2, A. F. JORM1, H. CREASEY2 and G. A. BROE2

1National Health and Medical Research Council Social Psychiatry Research Unit, Australian National University Canberra 2Department of Geriatric Medicine, University of Sydney, Repatriation General Hospital Concord, Australia

Correspondence to: Correspondence to: H. Christensen, NH and MRC Social Psychiatry Research Unit, Australian National University, PO Box 4, Canberra 2601, Australia.

The performance of 44 Alzheimer patients and 33 controls was examined on tests previously found to be differentially affected by scopolamine administration. Tests of secondary memory, performance intelligence, primary memory, semantic retrieval, procedural memory and verbal intelligence were included. It was found that Alzheimer patients performed more poorly than controls on tests of secondary memory, as measured by selective reminding, recall and recognition. Procedural memory, as measured by stem completion, homophone spelling and transformed text reading, did not differ between Alzheimer patients and controls. Semantic memory, verbal intelligence and primary memory were impaired in moderate and severe cases. However, patients with ‘mild’ dementia, as measured by the Mini-Mental State Examination, did not differ from controls on tests of semantic memory, verbal intelligence and primary memory. It was concluded that the pattern of anterograde memory deficits and preserved abilities in mild dementia mimicked that previously observed in scopolamine administration in young subjects.

Received February 18, 1992. Revised May 19, 1992. Accepted June 30, 1992.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BrainHome page
R. J. Perry and J. R. Hodges
Attention and executive deficits in Alzheimer's disease: A critical review
Brain, March 1, 1999; 122(3): 383 - 404.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. W. Decker, A. W. Bannon, P. Curzon, K. L. Gunther, J. D. Brioni, M. W. Holladay, N.-H. Lin, Y. Li, J. F. Daanen, J. J. Buccafusco, et al.
ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A Novel Cholinergic Channel Modulator with Effects on Cognitive Performance in Rats and Monkeys
J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 247 - 258.
[Abstract] [Full Text]


Home page
BMJHome page
N Maltby, G A Broe, H Creasey, A F Jorm, H Christensen, and W S Brooks
Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial
BMJ, April 2, 1994; 308(6933): 879 - 883.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.